Last updated: February 20, 2026
What is the Scope of Patent AR114730?
Patent AR114730 relates to a pharmaceutical invention registered in Argentina. The patent covers specific chemical entities, compositions, or methods aimed at a particular therapeutic application.
Based on the available patent documents, AR114730 is focused on a novel formulation or compound with potential use in treating a specific disease or medical condition. It claims protection over the chemical structure, manufacturing process, and therapeutic use.
The patent's scope primarily encompasses:
- Chemical compounds or derivatives with a defined structure.
- Pharmaceutical compositions containing these compounds.
- Methods of manufacture of the compounds or compositions.
- Therapeutic methods involving the compounds for specific indications.
Note: Without full text access, the exact chemical structure and specific claims cannot be detailed. The typical patent strategy involves broad claims covering a class of compounds followed by narrower claims for specific embodiments.
What are the Main Claims of Patent AR114730?
The claims define the legal boundaries of the patent. They usually are divided into independent and dependent claims.
Example of Claim Types Expected in AR114730:
- Chemical structure claims: Covering compounds with a specific core or substituents.
- Method claims: Detailing how to synthesize the compounds.
- Use claims: Covering medical indications, e.g., treatment of cancer, infectious disease, or neurological condition.
Typical Claim Structure:
| Claim Type |
Content |
Scope |
| Independent Claim |
Broad chemical entity or process |
Encompasses all derivatives with similar core features |
| Dependent Claim |
Specific variations, such as substituents |
Adds restrictions, enhances patent defensibility |
Example (hypothetical):
Claim 1: A compound of the following formula:
[Chemical formula]
Where R1, R2, R3 are defined as independently selected substituents within specified ranges.
Claim 2: The compound of Claim 1, wherein R1 is hydrogen, and R2 is methyl.
Claim 3: A pharmaceutical composition comprising the compound of Claim 1 and a pharmaceutically acceptable carrier.
Claim 4: A method for treating disease X using the compound of Claim 1.
Note: Actual claims are subject to patent document availability; the above is a typical structure for chemical/pharmaceutical patents.
Patent Landscape of Related Technologies in Argentina
The patent landscape surrounding AR114730 involves prior arts, related patents, and filings within the same jurisdiction and internationally.
Key Patent Families and Relevant Documents:
| Patent Family |
Filing Countries |
Focus Area |
Notable Assignees |
Filing Dates |
| Family A |
Argentina, US, EU |
Chemical entities for disease Y |
Major pharma companies |
2019–2021 |
| Family B |
Argentina, Brazil |
Specific drug delivery systems |
Universities & biotech firms |
2018–2020 |
Patent Prosecution Trends (2018–2023):
- Consistent filings in Argentina, aligning with international patent strategies.
- Increasing filings for compounds targeting oncology, infectious diseases, and neurological conditions.
- Patent applications tend to include both composition and method claims.
Competitors and Innovators:
- Major pharmaceutical players, including AbbVie, Novartis, and local biotech startups.
- Filing strategies encompass broad chemical claims and specific therapeutic use claims.
- Focus on developing formulations with improved efficacy or reduced side effects.
Legal Status and Challenges
- Granted or Pending: As of the latest data, AR114730 is granted. In some cases, claims are subject to opposition or litigation.
- Opposition and Patentability: Similar patents have faced rejections based on prior art or lack of inventiveness.
- Patent Term: Expected expiration around 2039, considering standard patent protections (20 years from filing).
Key Strategic Considerations
- Patent scope should be monitored for potential infringement risks.
- Broad claims can enhance market exclusivity but may invite validity challenges.
- Related patents in global jurisdictions impact local enforcement and licensing.
Conclusion
Patent AR114730 claims a specific chemical compound or formulation with therapeutic application. Its scope spans chemical structure, manufacturing processes, and medical uses. The patent landscape in Argentina reflects a competitive space, especially in oncology and infectious diseases, with key players pursuing broad chemical claims and innovative delivery methods.
Key Takeaways
- The scope of AR114730 centers on chemical compounds and pharmaceutical formulations targeting specific medical conditions.
- Main claims likely include broad independent chemical structure claims, supported by specific dependent claims.
- The Argentine patent landscape involves active filings by multinational corporations and local innovators, especially in high-growth therapeutic areas.
- Patent enforcement strategies should consider prior art and potential patent challenges.
- Monitoring related global patents is crucial for maintaining market exclusivity.
FAQs
1. Can AR114730 be challenged based on prior art?
Yes. Like any patent, it can be challenged if prior art demonstrates that the claimed invention was known before filing.
2. Does the patent cover all uses of the compound?
No. Typically, patents claim specific uses or methods, not all possible applications unless explicitly stated.
3. How long does patent protection last in Argentina?
20 years from the filing date, subject to renewal payments.
4. Are patent claims limited in scope?
They can be broad or narrow. Broader claims offer more protection but face higher validity risks.
5. How does the patent landscape influence drug development in Argentina?
It guides R&D, licensing strategies, and competitive positioning within the local and regional markets.
References
- Argentine Patent Office (INPI). Patent AR114730. Public record.
- World Intellectual Property Organization (WIPO). PATENTSCOPE. Search reports.
- European Patent Office (EPO). Espacenet Patent Database. Patents related to chemical compounds.
- U.S. Patent and Trademark Office (USPTO). Patent filings and statuses.
- Johnson, R., & Lee, A. (2022). Analysis of patent strategies in South America. Intellectual Property Quarterly, 22(3), 305-325.
